Table 2. | Implant stability quotient values over time in test and control group with relative inter- and intra-group comparisons |
| Control | Test | P-value | |
|---|---|---|---|
| Non activated | Plasma activated | ||
| Mean (SD) | Mean (SD) | ||
| Baseline | 77.1 (9) | 74.8 (10.5) | 0.41 |
| 7 days | 75.0 (9.9) | 74.3 (10.9) | 0.77 |
| 14 days | 71.9 (16.3) | 71.7 (12.4) | 0.65 |
| 21 days | 71.1 (14.2) | 71.3 (11.2) | 0.97 |
| 28 days | 71.3 (12.3) | 71.8 (10.6) | 0.7 |
| 42 days | 72.5 (9.6) | 73.2 (10) | 0.38 |
| 60 days | 74.0 (9) | 75.9 (8.9) | 0.04a |
| 90 days | 76.5 (8.2) | 77.2 (8.8) | 0.03a |
| P-value | 0.000b | 0.000b |
aStatistically significant at level P < 0.05 (two sample Wilcoxon rank-sum test).
|
.png)